Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients
Yin Yang, Yuqi Wu, Jingjing Zhao, Tao Zhang, Kailun Fei, Xiaotian Zhao, Lei Deng, Zhihui Zhang, Ying Jiang, Jianyang Wang, Wenyang Liu, Xin Wang, Song Wang, Hua Bao, Xue Wu, Minyi Zhu, Qiuxiang Ou, Wei Tang, Luhua Wang, Zhijie Wang, Nan Bi
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLung Cancer Research Studies · Cancer Genomics and Diagnostics · Cancer Immunotherapy and Biomarkers
Correction to: Signal Transduction and Targeted Therapy 10.1038/s41392-025-02445-y, published online 16 October 2025
After online publication of the article^1^, the authors noticed one inadvertent mistake in Acknowledgements part that needs to be corrected. The correct grant number for the “National High Level Hospital Clinical Research Funding” should be “2022-CICAMS-80102022503”.
The key findings of the article are not affected by these corrections.
The original version of this article is corrected.